Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines?
Open Access
- 1 November 2006
- journal article
- Published by FapUNIFESP (SciELO) in Memórias do Instituto Oswaldo Cruz
- Vol. 101 (7), 741-748
- https://doi.org/10.1590/s0074-02762006000700006
Abstract
Emerging resistance phenotypes and antimicrobial resistance rates among pathogens recovered from community-acquired urinary tract infections (CA-UTI) is an increasing problem in specific regions, limiting therapeutic options. As part of the SENTRY Antimicrobial Surveillance Program, a total of 611 isolates were collected in 2003 from patients with CA-UTI presenting at Latin American medical centers. Each strain was tested in a central laboratory using Clinical Laboratory Standard Institute (CLSI) broth microdilution methods with appropriate controls. Escherichia coli was the leading pathogen (66%), followed by Klebsiella spp. (7%), Proteus mirabilis (6.4%), Enterococcus spp. (5.6%), and Pseudomonas aeruginosa (4.6%). Surprisingly high resistance rates were recorded for E. coli against first-line orally administered agents for CA-UTI, such as ampicillin (53.6%), TMP/SMX (40.4%), ciprofloxacin (21.6%), and gatifloxacin (17.1%). Decreased susceptibility rates to TMP/SMX and ciprofloxacin were also documented for Klebsiella spp. (79.1 and 81.4%, respectively), and P. mirabilis (71.8 and 84.6%, respectively). For Enterococcus spp., susceptibility rates to ampicillin, chloramphenicol, ciprofloxacin, and vancomycin were 88.2, 85.3, 55.9, and 97.1%, respectively. High-level resistance to gentamicin was detected in 24% of Enterococcus spp. Bacteria isolated from patients with CA-UTI in Latin America showed limited susceptibility to orally administered antimicrobials, especially for TMP/SMX and fluoroquinolones. Our results highlight the need for developing specific CA-UTI guidelines in geographic regions where elevated resistance to new and old compounds may influence prescribing decisions.Universidade Federal de São Paulo (UNIFESP) Laboratório Especial de Microbiologia ClínicaJMI LaboratoriesUNIFESP, Laboratório Especial de Microbiologia ClínicaSciELKeywords
This publication has 27 references indexed in Scilit:
- The relationship between primary care antibiotic prescribing and bacterial resistance in adults in the community: a controlled observational study using individual patient dataJournal of Antimicrobial Chemotherapy, 2005
- Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical dataClinical Microbiology & Infection, 2005
- Cefdinir activity against contemporary North American isolates from community-acquired urinary tract infectionsInternational Journal of Antimicrobial Agents, 2005
- Bacterial resistance to antimicrobials in urinary isolatesInternational Journal of Antimicrobial Agents, 2004
- Once Daily, Extended Release Ciprofloxacin for Complicated Urinary Tract Infections and Acute Uncomplicated PyelonephritisJournal of Urology, 2004
- Multidrug‐ResistantEscherichia coliClonal Groups Causing Community‐Acquired PyelonephritisClinical Infectious Diseases, 2004
- Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001)Journal of Antimicrobial Chemotherapy, 2003
- Antimicrobial Resistance Among Uropathogens that Cause Community‐Acquired Urinary Tract Infections in Women: A Nationwide AnalysisClinical Infectious Diseases, 2001
- The ECOSENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens--interim reportJournal of Antimicrobial Chemotherapy, 2000
- Guidelines for Antimicrobial Treatment of Uncomplicated Acute Bacterial Cystitis and Acute Pyelonephritis in WomenClinical Infectious Diseases, 1999